An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings

Ítems similars

• Impact of the US Food and Drug Administration registration of antiretroviral drugs on global access to HIV treatment
  per: Chahal, Harinder Singh, et al.
  Publicat: (2018)
• The US Food and Drug Administration's tentative approval process and the global fight against HIV
  per: Chahal, Harinder Singh, et al.
  Publicat: (2017)
• Considerations for the Design and Conduct of a Pharmacovigilance Study Involving Mass Drug Administration in a Resource-Constrained Setting
  per: Alemayehu, Demissie, et al.
  Publicat: (2010)
• Public Disclosure of the Filing of New Drug and Therapeutic Biologics Applications With the US Food and Drug Administration
  per: Chahal, Harinder Singh, et al.
  Publicat: (2019)
• Contents of US Food and Drug Administration Refuse-to-File Letters for New Drug Applications and Efficacy Supplements and Their Public Disclosure by Applicants
  per: Chahal, Harinder Singh, et al.
  Publicat: (2021)